Search results
Supplies of Wegovy and Other Weight Loss Drugs Can Now Be Tracked by Patients
Gizmodo via Yahoo News· 6 days agoAs Novo Nordisk and Eli Lilly struggle to keep up with soaring demand for their popular diabetes and...
Shape's Dietary Supplement Methodology
Shape via Yahoo News· 1 hour agoWhat We Don't Recommend We don’t recommend potentially dangerous products (beyond the typical risks associated with nutritional supplements), or those...
Ozempic and weight loss drug shortages can now be tracked by patients
Quartz· 6 days agoAs Novo Nordisk and Eli Lilly struggle to keep up with soaring demand for their popular diabetes and...
France against Servier selling generics unit Biogaran, PM says
Reuters via AOL· 6 days agoPARIS (Reuters) -The French government has told drugmaker Servier it is against any sale of its...
This Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors
Motley Fool via Yahoo Finance· 3 days agoNovo Nordisk and Eli Lilly are the early leaders in the GLP-1 weight loss market, but that may not...
CNBC Daily Open: GameStop can't stop, Dow drops
CNBC· 15 hours agoA screen displays the logo and trading information for GameStop on the floor of the New York Stock Exchange. This report is from today's CNBC Daily Open,...
For those who wished for "a magic fix" for weight loss, Ozempic craze can trigger complicated...
CBS News· 3 days agoWhile research has looked at the potential mental health impact of taking semaglutide drugs like...
This Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors | The Motley Fool
The Motley Fool· 3 days agoEli Lilly (LLY 0.65%) and Novo Nordisk (NVO 1.87%) are the two most valuable healthcare companies in...
AstraZeneca CEO Has No Plans to Retire as He Seeks to Nearly Double Sales by 2030
The Wall Street Journal· 4 days agoAstraZeneca’s longest-serving chief executive, Pascal Soriot, has no plans to step down for now as...
Is Eli Lilly Stock A Buy On A Recent Crohn's Disease-Related Rally?
Investor's Business Daily· 5 days agoIn the first quarter, sales of weight-loss drug Zepbound skyrocketed and topped Wall Street's...
